PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2114451-5	1990	In the large granule fraction, a recovery of membrane-bound tyrosinase (T3) is seen following both MS and SW treatments, whereas dNM treatment results in the substantial loss of T3 tyrosinase.	1-Deoxynojirimycin	129-132	tyrosinase	Mus musculus	181-191	
2114451-6	1990	At the electron microscopic level, a translocation of tyrosinase from GERL and coated vesicles to many unmelanized vacuolar premelanosomes occurs in MS-treated cells in contrast to its predominant distribution in the GERL-coated vesicle system of dNM-treated cells, which contain many unmelanized premelanosomes.	1-Deoxynojirimycin	247-250	tyrosinase	Mus musculus	54-64	
12051746-2	2002	We have previously shown that tyrosinase inhibition requires high NB-DNJ concentrations, suggesting an inefficient cellular uptake of the drug.	1-Deoxynojirimycin	69-72	tyrosinase	Mus musculus	30-40